Skip to main content
Biogen Inc. (BMV:BIIB)
Mexico flag Mexico · Delayed Price · Currency is MXN
3,290.00
-54.00 (-1.61%)
At close: Nov 28, 2025

Revenue

Fiscal year is January - December.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 2013 - 2020
Period Ending
 Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2013 - 2020
Multiple Sclerosis Product Revenue
4.19B4.35B
Log In
Log In
Log In
Upgrade
Rare Disease Product Revenue
2.17B1.99B
Log In
Log In
Log In
Upgrade
Biosimilars Product Revenue
760.80M793.10M
Log In
Log In
Log In
Upgrade
Other Product Revenue
157.10M82.50M
Log In
Log In
Log In
Upgrade
Revenue (Other)
2.78B2.46B
Log In
Log In
Log In
Upgrade
Revenue (Total)
10.07B9.68B
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 2013 - 2020
Period Ending
 Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2013 - 2020
United States Revenue
3.46B3.24B
Log In
Log In
Log In
Upgrade
Rest of World Revenue
3.82B3.98B
Log In
Log In
Log In
Upgrade
Revenue (Other)
2.78B2.46B
Log In
Log In
Log In
Upgrade
Revenue (Total)
10.07B9.68B
Log In
Log In
Log In
Upgrade